Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Antigen Targeting to Dendritic Cells Allows the Identification of a CD4 T-Cell Epitope within an Immunodominant Trypanosoma cruzi Antigen

Full text
Author(s):
Rampazo, Eline V. [1] ; Amorim, Kelly N. S. [1] ; Yamamoto, Marcio M. [1] ; Panatieri, Raquel Hoffmann [1] ; Rodrigues, Mauricio M. [2, 3] ; Boscardin, Silvia B. [2, 1]
Total Authors: 6
Affiliation:
[1] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Lab Antigen Targeting Dendrit Cells, Sao Paulo - Brazil
[2] Natl Inst Sci & Technol Vaccines, Belo Horizonte, MG - Brazil
[3] Univ Fed Sao Paulo, CTCMol, Sao Paulo - Brazil
Total Affiliations: 3
Document type: Journal article
Source: PLoS One; v. 10, n. 2 FEB 13 2015.
Web of Science Citations: 11
Abstract

Targeting antigens to dendritic cells (DCs) by using hybrid monoclonal antibodies (mAbs) directed against DC receptors is known to improve activation and support long-lasting T cell responses. In the present work, we used the mAb alpha DEC205 fused to the Trypanosoma cruzi amastigote surface protein 2 (ASP-2) to identify a region of this protein recognized by specific T cells. The hybrid alpha DEC-ASP2 mAb was successfully generated and preserved its ability to bind the DEC205 receptor. Immunization of BALB/c mice with the recombinant mAb in the presence of polyriboinosinic: polyribocytidylic acid (poly (I:C)) specifically enhanced the number of IFN-gamma producing cells and CD4+ T cell proliferation when compared to mice immunized with a mAb without receptor affinity or with the non-targeted ASP-2 protein. The strong immune response induced in mice immunized with the hybrid alpha DEC-ASP2 mAb allowed us to identify an ASP-2-specific CD4+ T cell epitope recognized by the BALB/c MHCII haplotype. We conclude that targeting parasite antigens to DCs is a useful strategy to enhance T cell mediated immune responses facilitating the identification of new T-cell epitopes. (AU)

FAPESP's process: 07/08648-9 - Recombinant antigen targeting to dendritic cells in vivo: a new strategy for the development of vaccines
Grantee:Silvia Beatriz Boscardin
Support Opportunities: Research Grants - Young Investigators Grants